Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/%C2%BFsu-paciente-tiene-un-trastorno-depresivo-mayor-inmunometab%C3%B3lico Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Destaques do ECNP 2021 | Parte 02 Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter clicked Clicked https://progress.im/es/content/%C3%82%C2%BFsu-paciente-tiene-un-trastorno-depresivo-mayor-inmunometab%C3%83%C2%B3lico Gäst
Newsletter subscribed Newsletter subscribed - Boletín informativo de Progress in Mind LATAM Gäst
User created User created Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/perspectivas-sobre-el-futuro-de-la-psiquiatr%C3%ADa-tratamiento-y-capacitaci%C3%B3n Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/la-vulnerabilidad-individual-los-trastornos-del-estado-de-%C3%A1nimo-y-el-estr%C3%A9s-ser%C3%A1-predecible Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/evaluar-o-no-evaluar-en-un-primer-episodio-de-psicosis Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/%C2%BFsu-paciente-tiene-un-trastorno-depresivo-mayor-inmunometab%C3%B3lico Gäst
Newsletter opened Opened Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/%C2%BFsu-paciente-tiene-un-trastorno-depresivo-mayor-inmunometab%C3%B3lico Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/%C2%BFsu-paciente-tiene-un-trastorno-depresivo-mayor-inmunometab%C3%B3lico Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Destaques do ECNP 2021 | Parte 02 Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst
Newsletter clicked Clicked https://progress.im/es/content/%C3%82%C2%BFsu-paciente-tiene-un-trastorno-depresivo-mayor-inmunometab%C3%83%C2%B3lico Gäst
Newsletter subscribed Newsletter subscribed - Boletín informativo de Progress in Mind LATAM Gäst
User created User created Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/perspectivas-sobre-el-futuro-de-la-psiquiatr%C3%ADa-tratamiento-y-capacitaci%C3%B3n Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/la-vulnerabilidad-individual-los-trastornos-del-estado-de-%C3%A1nimo-y-el-estr%C3%A9s-ser%C3%A1-predecible Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/evaluar-o-no-evaluar-en-un-primer-episodio-de-psicosis Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/%C2%BFsu-paciente-tiene-un-trastorno-depresivo-mayor-inmunometab%C3%B3lico Gäst
Newsletter opened Opened Gäst
Newsletter clicked Clicked https://latam.progress.im/es/content/%C2%BFsu-paciente-tiene-un-trastorno-depresivo-mayor-inmunometab%C3%B3lico Gäst
Newsletter opened Opened Gäst
Newsletter opened Opened Gäst